dilactitol tyramine has been researched along with Lung Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Basu, A; Goldenberg, DM; Mattes, MJ; Stein, R; Thorpe, SR | 1 |
| Goldenberg, DM; Mattes, MJ; Stein, R; Thorpe, SR | 1 |
2 other study(ies) available for dilactitol tyramine and Lung Neoplasms
| Article | Year |
|---|---|
Effects of radiolabeling monoclonal antibodies with a residualizing iodine radiolabel on the accretion of radioisotope in tumors.
Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Catalysis; Female; Humans; Immunotoxins; Indium Radioisotopes; Iodine Radioisotopes; Isotope Labeling; Lung Neoplasms; Mice; Mice, Inbred Strains; Radioimmunotherapy; Tissue Distribution; Transplantation, Heterologous; Tumor Cells, Cultured; Tyramine | 1995 |
Advantage of a residualizing iodine radiolabel for radioimmunotherapy of xenografts of human non-small-cell carcinoma of the lung.
Topics: Animals; Antibodies, Monoclonal; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Female; Humans; Iodine Radioisotopes; Lung Neoplasms; Mice; Mice, Nude; Neoplasm Transplantation; Radioimmunotherapy; Radionuclide Imaging; Radiotherapy Dosage; Remission Induction; Tissue Distribution; Transplantation, Heterologous; Tyramine | 1997 |